← Leaderboards
John P. Arciero
Ipaces, Llc
$768,127
Attributed
$6,601,275
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,601,275 · 2
By mechanism
R44$6,601,275 · 2
Top collaborators
- Cay Anderson-Hanley6 shared
- Paul J Arciero6 shared
- David Arthur Merrill6 shared
- Stella E Panos6 shared
- Emilie Saulnier6 shared
- Sean Clark3 shared
- Mina Dunnam3 shared
- Robert Willson Gillen3 shared
Most similar at Ipaces, Llc
Same institution · by research overlap
- David Arthur Merrill$768,127
- Stella E Panos$768,127
- Paul J Arciero$768,127
- Robert Willson Gillen$408,129
- Eric Steven Molho$408,129
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposCommercializationMild Cognitive ImpairmentS Disease Related DementiaVideo GamesCognitivePlayPilot TrialPublishingRemediationExergameUpdateTabletsCognitive BenefitsExerciseFundingNeuropsychologyClinical TrialsPreventionDecision MakingDementiaDestinationsBehavioralComparative Efficacy
Grant awards (6)
Neuro-exergaming for the Prevention and Remediation of Decline due to Parkinson's Disease: Clinical Trial of the Interactive Physical and Cognitive Exercise System (iPACES v3)$1,373,201
R44 · FY2025 · NS
Neuro-exergaming for the Prevention and Remediation of Decline due to Parkinson's Disease: Clinical Trial of the Interactive Physical and Cognitive Exercise System (iPACES v3)$1,381,504
R44 · FY2024 · NS
Neuro-exergaming for the Prevention and Remediation of Decline due to Parkinson's Disease: Clinical Trial of the Interactive Physical and Cognitive Exercise System (iPACES v3)$1,326,588
R44 · FY2023 · NS
Neuro-exergaming for the prevention and remediation of decline due to Alzheimer's disease and related dementias: A clinical trial of the interactive Physical and Cognitive Exercise System (iPACES v3)$50,000
R44 · FY2022 · AG
Neuro-exergaming for the prevention and remediation of decline due to Alzheimer's disease and related dementias: A clinical trial of the interactive Physical and Cognitive Exercise System (iPACES v3)$1,116,991
R44 · FY2021 · AG
Neuro-exergaming for the prevention and remediation of decline due to Alzheimer's disease and related dementias: A clinical trial of the interactive Physical and Cognitive Exercise System (iPACES v3)$1,352,991
R44 · FY2020 · AG